Protein Number,Hit Name,Accession,E-value,Description,
2,Ion_trans,PF00520.30,5.5e-33,Ion transport protein,
2,TRP_2,PF08344.10,1.4e-26,Transient receptor ion channel II,
2,PKD_channel,PF08016.11,1.1e-12,Polycystin cation channel,
2,Ank_2,PF12796.6,2.6e-10,Ankyrin repeats (3 copies),
2,Ank_5,PF13857.5,2.2e-07,Ankyrin repeats (many copies),
2,Ank_4,PF13637.5,3.8e-06,Ankyrin repeats (many copies),
2,Ank_3,PF13606.5,1.1e-05,Ankyrin repeat,
2,Ank,PF00023.29,0.00023,Ankyrin repeat,
3,Ion_trans,PF00520.30,3.0e-23,Ion transport protein,
3,Ion_trans_N,PF08412.9,3.3e-20,Ion transport protein N-terminal,
3,cNMP_binding,PF00027.28,4.4e-18,Cyclic nucleotide-binding domain,
4,Neur_chan_memb,PF02932.15,1.1e-62,Neurotransmitter-gated ion-channel transmembrane region,
4,Neur_chan_LBD,PF02931.22,1.2e-32,Neurotransmitter-gated ion-channel ligand binding domain,
5,NAD_binding_6,PF08030.11,3.0e-31,Ferric reductase NAD binding domain,
5,FAD_binding_8,PF08022.11,2.0e-21,FAD-binding domain,
5,Ferric_reduct,PF01794.18,5.7e-21,Ferric reductase like transmembrane component,
5,EF-hand_1,PF00036.31,1.2e-17,EF hand,
5,EF-hand_5,PF13202.5,3.7e-15,EF hand,
5,EF-hand_6,PF13405.5,4.8e-15,EF-hand domain,
5,EF-hand_7,PF13499.5,1.8e-10,EF-hand domain pair,
5,EF-hand_8,PF13833.5,5.2e-07,EF-hand domain pair,
5,NAD_binding_1,PF00175.20,8.9e-05,Oxidoreductase NAD-binding domain,
6,Ion_trans,PF00520.30,5.3e-33,Ion transport protein,
6,TRP_2,PF08344.10,1.2e-25,Transient receptor ion channel II,
6,PKD_channel,PF08016.11,8.7e-12,Polycystin cation channel,
6,Ank_2,PF12796.6,8.6e-10,Ankyrin repeats (3 copies),
7,TRPM_tetra,PF16519.4,4.6e-24,Tetramerisation domain of TRPM,
7,Ion_trans,PF00520.30,3.9e-18,Ion transport protein,
8,Ion_trans,PF00520.30,3.5e-245,Ion transport protein,
8,Na_trans_assoc,PF06512.12,9.3e-40,Sodium ion transport-associated,
8,PKD_channel,PF08016.11,4.5e-11,Polycystin cation channel,
8,GPHH,PF16905.4,1.5e-06,Voltage-dependent L-type calcium channel, IQ-associated,
9,Ion_trans_2,PF07885.15,4.3e-23,Ion channel,
10,GST_C_2,PF13410.5,1.7e-07,Glutathione S-transferase, C-terminal domain,
11,MARVEL,PF01284.22,8.0e-21,Membrane-associating domain,
12,IRK,PF01007.19,4.9e-137,Inward rectifier potassium channel,
13,Neur_chan_LBD,PF02931.22,3.0e-49,Neurotransmitter-gated ion-channel ligand binding domain,
13,Neur_chan_memb,PF02932.15,1.0e-47,Neurotransmitter-gated ion-channel transmembrane region,
14,Neur_chan_LBD,PF02931.22,1.4e-51,Neurotransmitter-gated ion-channel ligand binding domain,
14,Neur_chan_memb,PF02932.15,6.0e-35,Neurotransmitter-gated ion-channel transmembrane region,
15,Kv2channel,PF03521.13,1.9e-55,Kv2 voltage-gated K+ channel,
15,Ion_trans,PF00520.30,9.7e-49,Ion transport protein,
15,BTB_2,PF02214.21,1.9e-32,BTB/POZ domain,
15,Ion_trans_2,PF07885.15,3.1e-12,Ion channel,
16,BK_channel_a,PF03493.17,7.2e-29,Calcium-activated BK potassium channel alpha subunit,
16,Ion_trans,PF00520.30,4.6e-16,Ion transport protein,
16,Ion_trans_2,PF07885.15,1.7e-11,Ion channel,
17,ANF_receptor,PF01094.27,1.4e-77,Receptor family ligand binding region,
17,Lig_chan,PF00060.25,8.0e-54,Ligand-gated ion channel,
17,Lig_chan-Glu_bd,PF10613.8,2.0e-46,Ligated ion channel L-glutamate- and glycine-binding site,
17,SBP_bac_3,PF00497.19,2.9e-18,Bacterial extracellular solute-binding proteins, family 3,
17,Peripla_BP_6,PF13458.5,1.4e-07,Periplasmic binding protein,
18,GST_C_2,PF13410.5,8.9e-11,Glutathione S-transferase, C-terminal domain,
18,GST_N_3,PF13417.5,2.5e-08,Glutathione S-transferase, N-terminal domain,
18,GST_N_2,PF13409.5,7.7e-06,Glutathione S-transferase, N-terminal domain,
19,Ion_trans,PF00520.30,1.3e-14,Ion transport protein,
19,Ank_2,PF12796.6,2.8e-13,Ankyrin repeats (3 copies),
19,Ank,PF00023.29,2.4e-09,Ankyrin repeat,
19,Ank_5,PF13857.5,1.0e-08,Ankyrin repeats (many copies),
19,Ank_3,PF13606.5,1.3e-08,Ankyrin repeat,
19,Ank_4,PF13637.5,2.5e-07,Ankyrin repeats (many copies),
20,Aldo_ket_red,PF00248.20,6.2e-71,Aldo/keto reductase family,
21,BK_channel_a,PF03493.17,7.6e-33,Calcium-activated BK potassium channel alpha subunit,
21,Ion_trans,PF00520.30,7.1e-18,Ion transport protein,
21,Ion_trans_2,PF07885.15,5.9e-14,Ion channel,
21,TrkA_N,PF02254.17,1.7e-05,TrkA-N domain,
22,Sulfate_transp,PF00916.19,1.7e-110,Sulfate permease family,
22,STAS,PF01740.20,9.4e-22,STAS domain,
23,Claudin_2,PF13903.5,1.3e-29,PMP-22/EMP/MP20/Claudin tight junction,
23,PMP22_Claudin,PF00822.19,4.3e-06,PMP-22/EMP/MP20/Claudin family,
24,ABA_GPCR,PF12430.7,4.9e-42,Abscisic acid G-protein coupled receptor,
24,GPHR_N,PF12537.7,6.0e-29,The Golgi pH Regulator (GPHR) Family N-terminal,
25,IRK,PF01007.19,3.1e-144,Inward rectifier potassium channel,
26,Ion_trans,PF00520.30,4.2e-44,Ion transport protein,
26,BTB_2,PF02214.21,2.7e-23,BTB/POZ domain,
26,Ion_trans_2,PF07885.15,3.6e-11,Ion channel,
27,Neur_chan_LBD,PF02931.22,1.8e-49,Neurotransmitter-gated ion-channel ligand binding domain,
27,Neur_chan_memb,PF02932.15,9.1e-38,Neurotransmitter-gated ion-channel transmembrane region,
28,Lig_chan,PF00060.25,8.3e-36,Ligand-gated ion channel,
28,Lig_chan-Glu_bd,PF10613.8,5.0e-28,Ligated ion channel L-glutamate- and glycine-binding site,
28,SBP_bac_3,PF00497.19,4.7e-24,Bacterial extracellular solute-binding proteins, family 3,
28,ANF_receptor,PF01094.27,8.0e-15,Receptor family ligand binding region,
28,NMDAR2_C,PF10565.8,7.3e-11,N-methyl D-aspartate receptor 2B3 C-terminus,
29,Neur_chan_memb,PF02932.15,1.2e-86,Neurotransmitter-gated ion-channel transmembrane region,
29,Neur_chan_LBD,PF02931.22,7.3e-71,Neurotransmitter-gated ion-channel ligand binding domain,
30,TRIC,PF05197.12,2.6e-79,TRIC channel,
31,Ion_trans,PF00520.30,4.4e-31,Ion transport protein,
31,CLZ,PF16526.4,2.2e-30,C-terminal leucine zipper domain of cyclic nucleotide-gated channels,
31,cNMP_binding,PF00027.28,1.4e-17,Cyclic nucleotide-binding domain,
32,Ion_trans,PF00520.30,1.2e-21,Ion transport protein,
32,Ion_trans_N,PF08412.9,2.4e-20,Ion transport protein N-terminal,
32,cNMP_binding,PF00027.28,4.2e-18,Cyclic nucleotide-binding domain,
33,V-set,PF07686.16,9.8e-22,Immunoglobulin V-set domain,
34,Ion_trans,PF00520.30,1.6e-251,Ion transport protein,
34,Na_trans_assoc,PF06512.12,7.1e-60,Sodium ion transport-associated,
34,PKD_channel,PF08016.11,2.5e-12,Polycystin cation channel,
35,Ion_trans,PF00520.30,1.4e-19,Ion transport protein,
35,Ank_2,PF12796.6,2.2e-15,Ankyrin repeats (3 copies),
35,Ank_5,PF13857.5,1.8e-12,Ankyrin repeats (many copies),
35,Ank,PF00023.29,1.6e-11,Ankyrin repeat,
35,Ank_4,PF13637.5,4.4e-08,Ankyrin repeats (many copies),
35,Ank_3,PF13606.5,4.8e-08,Ankyrin repeat,
36,NAD_binding_6,PF08030.11,9.7e-34,Ferric reductase NAD binding domain,
36,Ferric_reduct,PF01794.18,5.3e-23,Ferric reductase like transmembrane component,
36,FAD_binding_8,PF08022.11,5.9e-22,FAD-binding domain,
37,CaKB,PF03185.14,1.7e-84,Calcium-activated potassium channel, beta subunit,
37,KcnmB2_inactiv,PF09303.9,2.0e-19,KCNMB2, ball and chain domain,
38,PMP22_Claudin,PF00822.19,9.0e-58,PMP-22/EMP/MP20/Claudin family,
38,Claudin_2,PF13903.5,2.2e-21,PMP-22/EMP/MP20/Claudin tight junction,
39,GST_C_2,PF13410.5,2.3e-07,Glutathione S-transferase, C-terminal domain,
39,GST_N_3,PF13417.5,0.00015,Glutathione S-transferase, N-terminal domain,
40,VGCC_alpha2,PF08473.10,1.1e-212,Neuronal voltage-dependent calcium channel alpha 2acd,
40,VWA_N,PF08399.10,4.8e-41,VWA N-terminal,
40,VWA,PF00092.27,1.6e-19,von Willebrand factor type A domain,
40,VWA_3,PF13768.5,5.4e-14,von Willebrand factor type A domain,
40,VWA_2,PF13519.5,3.6e-11,von Willebrand factor type A domain,
41,PMP22_Claudin,PF00822.19,9.4e-39,PMP-22/EMP/MP20/Claudin family,
41,Claudin_2,PF13903.5,3.1e-19,PMP-22/EMP/MP20/Claudin tight junction,
42,Alpha_kinase,PF02816.17,1.4e-41,Alpha-kinase family,
42,TRPM_tetra,PF16519.4,7.9e-27,Tetramerisation domain of TRPM,
42,Ion_trans,PF00520.30,8.7e-09,Ion transport protein,
43,TMEM37,PF15108.5,2.3e-95,Voltage-dependent calcium channel gamma-like subunit protein family,
44,Ion_trans,PF00520.30,7.0e-258,Ion transport protein,
44,Na_trans_cytopl,PF11933.7,1.0e-80,Cytoplasmic domain of voltage-gated Na+ ion channel,
44,Na_trans_assoc,PF06512.12,3.4e-60,Sodium ion transport-associated,
44,PKD_channel,PF08016.11,1.7e-07,Polycystin cation channel,
45,Ca_hom_mod,PF14798.5,1.2e-101,Calcium homeostasis modulator,
46,LRR_8,PF13855.5,2.2e-32,Leucine rich repeat,
46,LRR_4,PF12799.6,2.2e-11,Leucine Rich repeats (2 copies),
46,LRR_1,PF00560.32,1.3e-05,Leucine Rich Repeat,
47,Innexin,PF00876.17,2.1e-14,Innexin,
48,Innexin,PF00876.17,7.4e-14,Innexin,
49,ASC,PF00858.23,3.0e-106,Amiloride-sensitive sodium channel,
50,ISK_Channel,PF02060.14,9.2e-08,Slow voltage-gated potassium channel,
51,ISK_Channel,PF02060.14,1.2e-63,Slow voltage-gated potassium channel,
52,Ion_trans,PF00520.30,2.9e-43,Ion transport protein,
52,DUF3399,PF11879.7,2.2e-43,Domain of unknown function (DUF3399),
52,BTB_2,PF02214.21,6.4e-29,BTB/POZ domain,
52,Shal-type,PF11601.7,1.6e-14,Shal-type voltage-gated potassium channels, N-terminal,
52,Ion_trans_2,PF07885.15,3.6e-13,Ion channel,
52,BTB_3,PF16017.4,3.1e-05,BTB/POZ domain,
53,Ion_trans,PF00520.30,1.9e-33,Ion transport protein,
53,PKD_channel,PF08016.11,1.2e-06,Polycystin cation channel,
54,ISK_Channel,PF02060.14,1.5e-16,Slow voltage-gated potassium channel,
55,CLCA,PF08434.10,2.8e-117,Calcium-activated chloride channel N terminal,
56,Ion_trans,PF00520.30,8.9e-32,Ion transport protein,
56,PAS_9,PF13426.6,6.1e-19,PAS domain,
56,Ion_trans_2,PF07885.15,1.2e-11,Ion channel,
56,cNMP_binding,PF00027.28,2.1e-07,Cyclic nucleotide-binding domain,
56,PAS_4,PF08448.9,1.2e-06,PAS fold,
56,PAS_3,PF08447.11,2.2e-06,PAS fold,
56,PAS,PF00989.24,7.6e-06,PAS fold,
57,Ion_trans,PF00520.30,3.6e-49,Ion transport protein,
57,BTB_2,PF02214.21,2.9e-27,BTB/POZ domain,
57,Ion_trans_2,PF07885.15,3.7e-12,Ion channel,
58,Neur_chan_LBD,PF02931.22,1.5e-39,Neurotransmitter-gated ion-channel ligand binding domain,
58,Neur_chan_memb,PF02932.15,5.7e-17,Neurotransmitter-gated ion-channel transmembrane region,
59,Innexin,PF00876.17,3.8e-09,Innexin,
60,Ion_trans,PF00520.30,1.3e-32,Ion transport protein,
60,TRP_2,PF08344.10,2.8e-28,Transient receptor ion channel II,
60,Ank_2,PF12796.6,2.5e-11,Ankyrin repeats (3 copies),
60,Ank_4,PF13637.5,1.0e-06,Ankyrin repeats (many copies),
60,Ank_3,PF13606.5,1.6e-06,Ankyrin repeat,
60,Ank,PF00023.29,0.00017,Ankyrin repeat,
61,ATP1G1_PLM_MAT8,PF02038.15,2.6e-26,ATP1G1/PLM/MAT8 family,
62,Ion_trans,PF00520.30,1.1e-50,Ion transport protein,
62,BTB_2,PF02214.21,8.1e-27,BTB/POZ domain,
62,Ion_trans_2,PF07885.15,5.0e-13,Ion channel,
63,Ion_trans,PF00520.30,3.4e-33,Ion transport protein,
63,PKD_channel,PF08016.11,0.00019,Polycystin cation channel,
64,Ion_trans,PF00520.30,7.1e-51,Ion transport protein,
64,BTB_2,PF02214.21,1.7e-28,BTB/POZ domain,
64,Ion_trans_2,PF07885.15,1.1e-14,Ion channel,
65,Ion_trans,PF00520.30,1.1e-252,Ion transport protein,
65,GPHH,PF16905.4,1.7e-35,Voltage-dependent L-type calcium channel, IQ-associated,
65,Ca_chan_IQ,PF08763.10,5.3e-29,Voltage gated calcium channel IQ domain,
65,PKD_channel,PF08016.11,2.6e-12,Polycystin cation channel,
66,Ion_trans,PF00520.30,4.1e-258,Ion transport protein,
66,CAC1F_C,PF16885.4,2.2e-69,Voltage-gated calcium channel subunit alpha, C-term,
66,GPHH,PF16905.4,4.6e-36,Voltage-dependent L-type calcium channel, IQ-associated,
66,Ca_chan_IQ,PF08763.10,9.0e-31,Voltage gated calcium channel IQ domain,
66,PKD_channel,PF08016.11,2.8e-10,Polycystin cation channel,
67,Ion_trans,PF00520.30,6.4e-20,Ion transport protein,
68,ISK_Channel,PF02060.14,1.9e-08,Slow voltage-gated potassium channel,
69,ASC,PF00858.23,3.9e-97,Amiloride-sensitive sodium channel,
70,Ion_trans,PF00520.30,1.7e-35,Ion transport protein,
70,PAS_9,PF13426.6,1.4e-17,PAS domain,
70,cNMP_binding,PF00027.28,7.8e-12,Cyclic nucleotide-binding domain,
70,Ion_trans_2,PF07885.15,1.7e-11,Ion channel,
70,PAS,PF00989.24,1.9e-08,PAS fold,
70,PAS_3,PF08447.11,1.3e-06,PAS fold,
71,KCNQ_channel,PF03520.13,5.5e-91,KCNQ voltage-gated potassium channel,
71,KCNQC3-Ank-G_bd,PF11956.7,1.8e-46,Ankyrin-G binding motif of KCNQ2-3,
71,KCNQ2_u3,PF16642.4,1.8e-36,Unstructured region on Potassium channel subunit alpha KvLQT2,
71,Ion_trans,PF00520.30,1.4e-29,Ion transport protein,
71,Ion_trans_2,PF07885.15,1.1e-12,Ion channel,
72,KCNQ_channel,PF03520.13,1.6e-85,KCNQ voltage-gated potassium channel,
72,KCNQC3-Ank-G_bd,PF11956.7,1.3e-38,Ankyrin-G binding motif of KCNQ2-3,
72,Ion_trans,PF00520.30,7.7e-29,Ion transport protein,
72,Ion_trans_2,PF07885.15,1.2e-12,Ion channel,
73,Ion_trans,PF00520.30,1.6e-253,Ion transport protein,
73,PKD_channel,PF08016.11,5.0e-15,Polycystin cation channel,
74,NMDAR2_C,PF10565.8,1.9e-264,N-methyl D-aspartate receptor 2B3 C-terminus,
74,Lig_chan,PF00060.25,2.6e-35,Ligand-gated ion channel,
74,Lig_chan-Glu_bd,PF10613.8,3.3e-30,Ligated ion channel L-glutamate- and glycine-binding site,
74,SBP_bac_3,PF00497.19,1.1e-20,Bacterial extracellular solute-binding proteins, family 3,
74,ANF_receptor,PF01094.27,1.8e-12,Receptor family ligand binding region,
75,ASC,PF00858.23,7.8e-107,Amiloride-sensitive sodium channel,
76,IRK,PF01007.19,5.1e-156,Inward rectifier potassium channel,
76,IRK_N,PF08466.9,1.5e-26,Inward rectifier potassium channel N-terminal,
77,Ion_trans,PF00520.30,1.6e-30,Ion transport protein,
77,PAS_9,PF13426.6,6.0e-21,PAS domain,
77,Ion_trans_2,PF07885.15,6.0e-11,Ion channel,
77,PAS_3,PF08447.11,2.6e-09,PAS fold,
77,PAS,PF00989.24,1.5e-06,PAS fold,
77,PAS_4,PF08448.9,2.1e-06,PAS fold,
78,EF-hand_7,PF13499.5,4.4e-23,EF-hand domain pair,
78,EF-hand_1,PF00036.31,8.2e-23,EF hand,
78,EF-hand_6,PF13405.5,1.7e-18,EF-hand domain,
78,EF-hand_8,PF13833.5,1.5e-15,EF-hand domain pair,
78,EF-hand_5,PF13202.5,4.2e-15,EF hand,
78,SPARC_Ca_bdg,PF10591.8,2.5e-06,Secreted protein acidic and rich in cysteine Ca binding region,
78,EF-hand_4,PF12763.6,4.0e-05,Cytoskeletal-regulatory complex EF hand,
79,Ion_trans,PF00520.30,1.8e-36,Ion transport protein,
79,BTB_2,PF02214.21,2.8e-21,BTB/POZ domain,
79,Ion_trans_2,PF07885.15,6.0e-14,Ion channel,
80,Ion_trans,PF00520.30,1.6e-39,Ion transport protein,
80,BTB_2,PF02214.21,3.2e-27,BTB/POZ domain,
80,Ion_trans_2,PF07885.15,2.5e-14,Ion channel,
81,Tweety,PF04906.12,3.3e-174,Tweety,
82,IRK,PF01007.19,2.6e-134,Inward rectifier potassium channel,
83,Neur_chan_memb,PF02932.15,2.7e-86,Neurotransmitter-gated ion-channel transmembrane region,
83,Neur_chan_LBD,PF02931.22,2.1e-73,Neurotransmitter-gated ion-channel ligand binding domain,
84,PKD_channel,PF08016.11,7.9e-165,Polycystin cation channel,
84,Ion_trans,PF00520.30,1.6e-24,Ion transport protein,
85,IRK,PF01007.19,1.6e-152,Inward rectifier potassium channel,
86,IRK,PF01007.19,1.2e-143,Inward rectifier potassium channel,
87,IRK,PF01007.19,1.5e-143,Inward rectifier potassium channel,
88,ANF_receptor,PF01094.27,1.4e-63,Receptor family ligand binding region,
88,Lig_chan,PF00060.25,5.5e-60,Ligand-gated ion channel,
88,Lig_chan-Glu_bd,PF10613.8,7.4e-45,Ligated ion channel L-glutamate- and glycine-binding site,
88,SBP_bac_3,PF00497.19,1.2e-23,Bacterial extracellular solute-binding proteins, family 3,
89,CLCA,PF08434.10,1.5e-113,Calcium-activated chloride channel N terminal,
90,Neur_chan_LBD,PF02931.22,2.2e-51,Neurotransmitter-gated ion-channel ligand binding domain,
90,Neur_chan_memb,PF02932.15,1.2e-36,Neurotransmitter-gated ion-channel transmembrane region,
91,Voltage_CLC,PF00654.19,2.6e-93,Voltage gated chloride channel,
92,Ion_trans,PF00520.30,9.4e-26,Ion transport protein,
92,KCNQ_channel,PF03520.13,3.2e-25,KCNQ voltage-gated potassium channel,
92,Ion_trans_2,PF07885.15,1.3e-11,Ion channel,
93,Neur_chan_memb,PF02932.15,1.3e-68,Neurotransmitter-gated ion-channel transmembrane region,
93,Neur_chan_LBD,PF02931.22,9.6e-64,Neurotransmitter-gated ion-channel ligand binding domain,
94,Ion_trans,PF00520.30,3.8e-32,Ion transport protein,
94,PKD_channel,PF08016.11,2.9e-10,Polycystin cation channel,
95,Neur_chan_memb,PF02932.15,9.4e-74,Neurotransmitter-gated ion-channel transmembrane region,
95,Neur_chan_LBD,PF02931.22,8.0e-70,Neurotransmitter-gated ion-channel ligand binding domain,
96,Neur_chan_LBD,PF02931.22,4.4e-53,Neurotransmitter-gated ion-channel ligand binding domain,
96,Neur_chan_memb,PF02932.15,2.5e-35,Neurotransmitter-gated ion-channel transmembrane region,
97,Voltage_CLC,PF00654.19,1.8e-98,Voltage gated chloride channel,
97,CBS,PF00571.27,7.2e-16,CBS domain,
98,Voltage_CLC,PF00654.19,3.3e-95,Voltage gated chloride channel,
98,CBS,PF00571.27,1.8e-17,CBS domain,
99,Voltage_CLC,PF00654.19,4.4e-111,Voltage gated chloride channel,
99,CBS,PF00571.27,1.5e-13,CBS domain,
100,Voltage_CLC,PF00654.19,2.3e-109,Voltage gated chloride channel,
100,CBS,PF00571.27,4.4e-13,CBS domain,
101,Voltage_CLC,PF00654.19,1.5e-109,Voltage gated chloride channel,
101,CBS,PF00571.27,1.9e-13,CBS domain,
102,MCU,PF04678.12,7.5e-75,Mitochondrial calcium uniporter,
103,Neur_chan_LBD,PF02931.22,3.5e-50,Neurotransmitter-gated ion-channel ligand binding domain,
103,Neur_chan_memb,PF02932.15,3.0e-46,Neurotransmitter-gated ion-channel transmembrane region,
104,GST_C_2,PF13410.5,1.8e-08,Glutathione S-transferase, C-terminal domain,
104,GST_N_2,PF13409.5,1.3e-06,Glutathione S-transferase, N-terminal domain,
104,GST_N_3,PF13417.5,6.8e-06,Glutathione S-transferase, N-terminal domain,
105,ENTH,PF01417.19,4.2e-46,ENTH domain,
106,Bestrophin,PF01062.20,1.3e-110,Bestrophin, RFP-TM, chloride channel,
107,Bestrophin,PF01062.20,6.9e-112,Bestrophin, RFP-TM, chloride channel,
108,SK_channel,PF03530.13,4.9e-38,Calcium-activated SK potassium channel,
108,CaMBD,PF02888.15,1.3e-27,Calmodulin binding domain,
108,Ion_trans_2,PF07885.15,6.2e-15,Ion channel,
109,Guanylate_kin,PF00625.20,6.6e-50,Guanylate kinase,
109,VGCC_beta4Aa_N,PF12052.7,9.9e-23,Voltage gated calcium channel subunit beta domain 4Aa N terminal,
110,IRK,PF01007.19,3.0e-157,Inward rectifier potassium channel,
110,IRK_N,PF08466.9,6.4e-24,Inward rectifier potassium channel N-terminal,
111,Ion_trans,PF00520.30,3.3e-35,Ion transport protein,
111,PAS_9,PF13426.6,5.2e-17,PAS domain,
111,cNMP_binding,PF00027.28,5.7e-13,Cyclic nucleotide-binding domain,
111,Ion_trans_2,PF07885.15,1.9e-12,Ion channel,
111,PAS,PF00989.24,7.1e-07,PAS fold,
112,LRR_8,PF13855.5,9.3e-25,Leucine rich repeat,
112,LRR_4,PF12799.6,6.4e-11,Leucine Rich repeats (2 copies),
112,LRR_1,PF00560.32,1.6e-06,Leucine Rich Repeat,
113,Neur_chan_LBD,PF02931.22,6.6e-51,Neurotransmitter-gated ion-channel ligand binding domain,
113,Neur_chan_memb,PF02932.15,1.3e-39,Neurotransmitter-gated ion-channel transmembrane region,
114,Voltage_CLC,PF00654.19,8.4e-74,Voltage gated chloride channel,
114,CBS,PF00571.27,2.2e-10,CBS domain,
115,Voltage_CLC,PF00654.19,2.2e-74,Voltage gated chloride channel,
115,CBS,PF00571.27,4.5e-07,CBS domain,
116,Bestrophin,PF01062.20,7.9e-107,Bestrophin, RFP-TM, chloride channel,
117,CFTR_R,PF14396.5,2.7e-101,Cystic fibrosis TM conductance regulator (CFTR), regulator domain,
117,ABC_membrane,PF00664.22,4.1e-92,ABC transporter transmembrane region,
117,ABC_tran,PF00005.26,3.1e-59,ABC transporter,
117,AAA_21,PF13304.5,6.8e-08,AAA domain, putative AbiEii toxin, Type IV TA system,
117,AAA_29,PF13555.5,1.7e-06,P-loop containing region of AAA domain,
117,T2SSE,PF00437.19,4.5e-06,Type II/IV secretion system protein,
118,V-set,PF07686.16,8.4e-11,Immunoglobulin V-set domain,
119,P2X_receptor,PF00864.18,1.1e-157,ATP P2X receptor,
120,Ion_trans,PF00520.30,7.1e-27,Ion transport protein,
120,CLZ,PF16526.4,4.8e-21,C-terminal leucine zipper domain of cyclic nucleotide-gated channels,
120,cNMP_binding,PF00027.28,2.3e-18,Cyclic nucleotide-binding domain,
121,Ion_trans,PF00520.30,4.3e-51,Ion transport protein,
121,BTB_2,PF02214.21,7.1e-29,BTB/POZ domain,
121,Ion_trans_2,PF07885.15,4.5e-14,Ion channel,
122,IRK,PF01007.19,6.1e-145,Inward rectifier potassium channel,
123,Neur_chan_LBD,PF02931.22,3.1e-73,Neurotransmitter-gated ion-channel ligand binding domain,
123,Neur_chan_memb,PF02932.15,1.9e-62,Neurotransmitter-gated ion-channel transmembrane region,
124,ATP1G1_PLM_MAT8,PF02038.15,4.0e-27,ATP1G1/PLM/MAT8 family,
125,Ion_trans,PF00520.30,1.5e-55,Ion transport protein,
126,IRK,PF01007.19,1.0e-139,Inward rectifier potassium channel,
127,Ion_trans,PF00520.30,4.8e-45,Ion transport protein,
127,BTB_2,PF02214.21,6.3e-28,BTB/POZ domain,
127,Ion_trans_2,PF07885.15,2.7e-11,Ion channel,
128,Neur_chan_memb,PF02932.15,1.2e-73,Neurotransmitter-gated ion-channel transmembrane region,
128,Neur_chan_LBD,PF02931.22,3.2e-64,Neurotransmitter-gated ion-channel ligand binding domain,
129,EF-hand_7,PF13499.5,4.9e-23,EF-hand domain pair,
129,EF-hand_1,PF00036.31,1.0e-18,EF hand,
129,EF-hand_6,PF13405.5,6.1e-15,EF-hand domain,
129,EF-hand_8,PF13833.5,3.6e-14,EF-hand domain pair,
129,EF-hand_5,PF13202.5,4.1e-13,EF hand,
129,SPARC_Ca_bdg,PF10591.8,2.0e-05,Secreted protein acidic and rich in cysteine Ca binding region,
130,Ion_trans,PF00520.30,8.2e-265,Ion transport protein,
130,CAC1F_C,PF16885.4,2.5e-36,Voltage-gated calcium channel subunit alpha, C-term,
130,GPHH,PF16905.4,2.0e-36,Voltage-dependent L-type calcium channel, IQ-associated,
130,Ca_chan_IQ,PF08763.10,2.0e-30,Voltage gated calcium channel IQ domain,
130,PKD_channel,PF08016.11,6.0e-10,Polycystin cation channel,
131,Ion_trans_2,PF07885.15,5.4e-33,Ion channel,
131,Ion_trans,PF00520.30,5.5e-06,Ion transport protein,
132,Neur_chan_LBD,PF02931.22,1.7e-48,Neurotransmitter-gated ion-channel ligand binding domain,
132,Neur_chan_memb,PF02932.15,7.9e-30,Neurotransmitter-gated ion-channel transmembrane region,
133,Ion_trans_2,PF07885.15,5.9e-32,Ion channel,
133,Ion_trans,PF00520.30,1.6e-06,Ion transport protein,
134,GST_C_2,PF13410.5,1.7e-07,Glutathione S-transferase, C-terminal domain,
134,GST_N_3,PF13417.5,2.4e-06,Glutathione S-transferase, N-terminal domain,
135,Ion_trans,PF00520.30,2.3e-58,Ion transport protein,
136,Ion_trans_2,PF07885.15,1.3e-38,Ion channel,
136,Ion_trans,PF00520.30,5.6e-08,Ion transport protein,
137,MCLC,PF05934.10,0.0e+00,Mid-1-related chloride channel (MCLC),
138,Ion_trans,PF00520.30,1.0e-42,Ion transport protein,
138,BTB_2,PF02214.21,1.4e-30,BTB/POZ domain,
138,Ion_trans_2,PF07885.15,2.2e-13,Ion channel,
139,Ion_trans,PF00520.30,8.8e-43,Ion transport protein,
139,DUF3399,PF11879.7,1.2e-41,Domain of unknown function (DUF3399),
139,BTB_2,PF02214.21,1.4e-28,BTB/POZ domain,
139,Ion_trans_2,PF07885.15,2.0e-13,Ion channel,
139,Shal-type,PF11601.7,2.0e-13,Shal-type voltage-gated potassium channels, N-terminal,
139,BTB_3,PF16017.4,2.8e-05,BTB/POZ domain,
140,PKD_channel,PF08016.11,1.2e-128,Polycystin cation channel,
140,Ion_trans,PF00520.30,3.4e-19,Ion transport protein,
141,Ion_trans,PF00520.30,7.2e-12,Ion transport protein,
142,Anoctamin,PF04547.11,3.6e-159,Calcium-activated chloride channel,
142,Anoct_dimer,PF16178.4,3.7e-74,Dimerisation domain of Ca+-activated chloride-channel, anoctamin,
143,NAD_binding_6,PF08030.11,4.7e-39,Ferric reductase NAD binding domain,
143,Ferric_reduct,PF01794.18,4.6e-25,Ferric reductase like transmembrane component,
143,FAD_binding_8,PF08022.11,1.2e-22,FAD-binding domain,
143,FAD_binding_6,PF00970.23,0.00012,Oxidoreductase FAD-binding domain,
144,ANF_receptor,PF01094.27,6.8e-57,Receptor family ligand binding region,
144,Lig_chan,PF00060.25,1.1e-43,Ligand-gated ion channel,
144,Lig_chan-Glu_bd,PF10613.8,3.3e-39,Ligated ion channel L-glutamate- and glycine-binding site,
144,SBP_bac_3,PF00497.19,1.8e-25,Bacterial extracellular solute-binding proteins, family 3,
145,ASC,PF00858.23,1.0e-104,Amiloride-sensitive sodium channel,
146,ASC,PF00858.23,1.2e-87,Amiloride-sensitive sodium channel,
147,ASC,PF00858.23,8.4e-110,Amiloride-sensitive sodium channel,
148,ANF_receptor,PF01094.27,7.3e-49,Receptor family ligand binding region,
148,Lig_chan,PF00060.25,2.4e-42,Ligand-gated ion channel,
148,Lig_chan-Glu_bd,PF10613.8,1.5e-35,Ligated ion channel L-glutamate- and glycine-binding site,
148,SBP_bac_3,PF00497.19,2.0e-20,Bacterial extracellular solute-binding proteins, family 3,
149,Aldo_ket_red,PF00248.20,1.6e-67,Aldo/keto reductase family,
150,TMC,PF07810.12,4.8e-40,TMC domain,
151,Ion_trans,PF00520.30,7.3e-249,Ion transport protein,
151,GPHH,PF16905.4,7.7e-38,Voltage-dependent L-type calcium channel, IQ-associated,
151,Ca_chan_IQ,PF08763.10,1.5e-31,Voltage gated calcium channel IQ domain,
151,PKD_channel,PF08016.11,7.2e-09,Polycystin cation channel,
152,Ion_trans,PF00520.30,1.6e-259,Ion transport protein,
152,Na_trans_cytopl,PF11933.7,1.1e-73,Cytoplasmic domain of voltage-gated Na+ ion channel,
152,Na_trans_assoc,PF06512.12,2.8e-61,Sodium ion transport-associated,
152,PKD_channel,PF08016.11,9.7e-07,Polycystin cation channel,
152,IQ,PF00612.26,0.00012,IQ calmodulin-binding motif,
153,Neur_chan_LBD,PF02931.22,4.1e-52,Neurotransmitter-gated ion-channel ligand binding domain,
153,Neur_chan_memb,PF02932.15,3.3e-33,Neurotransmitter-gated ion-channel transmembrane region,
154,Ion_trans,PF00520.30,1.2e-32,Ion transport protein,
154,PKD_channel,PF08016.11,2.5e-05,Polycystin cation channel,
155,Ca_hom_mod,PF14798.5,6.2e-91,Calcium homeostasis modulator,
156,TRP_2,PF08344.10,4.7e-25,Transient receptor ion channel II,
156,Ion_trans,PF00520.30,9.1e-17,Ion transport protein,
156,Ank_2,PF12796.6,1.7e-06,Ankyrin repeats (3 copies),
156,Ank_4,PF13637.5,2.0e-05,Ankyrin repeats (many copies),
157,Neur_chan_LBD,PF02931.22,2.3e-38,Neurotransmitter-gated ion-channel ligand binding domain,
157,Neur_chan_memb,PF02932.15,7.4e-18,Neurotransmitter-gated ion-channel transmembrane region,
158,ATP1G1_PLM_MAT8,PF02038.15,1.9e-23,ATP1G1/PLM/MAT8 family,
159,Piezo_RRas_bdg,PF12166.7,9.2e-156,Piezo non-specific cation channel, R-Ras-binding domain,
159,PIEZO,PF15917.4,8.9e-95,Piezo,
160,TRPM_tetra,PF16519.4,1.2e-23,Tetramerisation domain of TRPM,
160,Ion_trans,PF00520.30,6.9e-20,Ion transport protein,
161,CLCA,PF08434.10,1.1e-148,Calcium-activated chloride channel N terminal,
161,VWA,PF00092.27,5.9e-13,von Willebrand factor type A domain,
161,VWA_2,PF13519.5,1.8e-11,von Willebrand factor type A domain,
162,Ion_trans,PF00520.30,3.6e-52,Ion transport protein,
162,BTB_2,PF02214.21,5.4e-27,BTB/POZ domain,
162,Ion_trans_2,PF07885.15,9.4e-14,Ion channel,
163,Ion_trans_2,PF07885.15,4.4e-38,Ion channel,
163,Ion_trans,PF00520.30,6.5e-07,Ion transport protein,
164,Ion_trans,PF00520.30,1.2e-49,Ion transport protein,
164,K_channel_TID,PF07941.10,4.5e-38,Potassium channel Kv1.4 tandem inactivation domain,
164,BTB_2,PF02214.21,4.7e-28,BTB/POZ domain,
164,Ion_trans_2,PF07885.15,2.9e-13,Ion channel,
165,TMC,PF07810.12,1.9e-39,TMC domain,
166,TMC,PF07810.12,4.8e-50,TMC domain,
167,Ion_trans,PF00520.30,1.3e-47,Ion transport protein,
167,BTB_2,PF02214.21,2.0e-19,BTB/POZ domain,
167,Ion_trans_2,PF07885.15,1.4e-12,Ion channel,
167,PKD_channel,PF08016.11,0.00023,Polycystin cation channel,
168,TMC,PF07810.12,1.9e-42,TMC domain,
169,Ion_trans_2,PF07885.15,3.6e-30,Ion channel,
170,Claudin_2,PF13903.5,1.6e-41,PMP-22/EMP/MP20/Claudin tight junction,
170,PMP22_Claudin,PF00822.19,1.1e-12,PMP-22/EMP/MP20/Claudin family,
171,ABA_GPCR,PF12430.7,4.9e-42,Abscisic acid G-protein coupled receptor,
171,GPHR_N,PF12537.7,6.0e-29,The Golgi pH Regulator (GPHR) Family N-terminal,
172,Ion_trans,PF00520.30,3.9e-52,Ion transport protein,
172,BTB_2,PF02214.21,5.5e-28,BTB/POZ domain,
172,Ion_trans_2,PF07885.15,2.1e-13,Ion channel,
173,Lig_chan,PF00060.25,5.1e-34,Ligand-gated ion channel,
173,Lig_chan-Glu_bd,PF10613.8,9.5e-29,Ligated ion channel L-glutamate- and glycine-binding site,
173,SBP_bac_3,PF00497.19,3.5e-23,Bacterial extracellular solute-binding proteins, family 3,
173,ANF_receptor,PF01094.27,1.3e-15,Receptor family ligand binding region,
174,P2X_receptor,PF00864.18,9.0e-141,ATP P2X receptor,
175,Ank_2,PF12796.6,7.5e-15,Ankyrin repeats (3 copies),
175,Ion_trans,PF00520.30,6.5e-15,Ion transport protein,
175,Ank,PF00023.29,1.3e-10,Ankyrin repeat,
175,Ank_5,PF13857.5,1.6e-09,Ankyrin repeats (many copies),
175,Ank_3,PF13606.5,4.5e-09,Ankyrin repeat,
175,Ank_4,PF13637.5,5.4e-07,Ankyrin repeats (many copies),
176,Ank_2,PF12796.6,8.1e-22,Ankyrin repeats (3 copies),
176,Ank_3,PF13606.5,1.8e-14,Ankyrin repeat,
176,Ank,PF00023.29,4.3e-14,Ankyrin repeat,
176,Ank_5,PF13857.5,1.3e-11,Ankyrin repeats (many copies),
176,Ion_trans,PF00520.30,3.6e-10,Ion transport protein,
176,Ank_4,PF13637.5,9.6e-09,Ankyrin repeats (many copies),
177,Tweety,PF04906.12,2.3e-163,Tweety,
178,LRR_8,PF13855.5,5.3e-30,Leucine rich repeat,
178,LRR_4,PF12799.6,1.2e-11,Leucine Rich repeats (2 copies),
178,LRR_9,PF14580.5,1.0e-08,Leucine-rich repeat,
178,LRR_5,PF13306.5,7.0e-08,Leucine rich repeats (6 copies),
178,LRR_1,PF00560.32,3.2e-07,Leucine Rich Repeat,
178,LRR_3,PF07725.11,0.00025,Leucine Rich Repeat,
179,Neur_chan_LBD,PF02931.22,1.7e-53,Neurotransmitter-gated ion-channel ligand binding domain,
179,Neur_chan_memb,PF02932.15,2.9e-38,Neurotransmitter-gated ion-channel transmembrane region,
180,SK_channel,PF03530.13,7.1e-49,Calcium-activated SK potassium channel,
180,CaMBD,PF02888.15,8.2e-39,Calmodulin binding domain,
180,Ion_trans_2,PF07885.15,7.6e-13,Ion channel,
181,Ion_trans,PF00520.30,1.4e-10,Ion transport protein,
182,Ank_2,PF12796.6,2.4e-25,Ankyrin repeats (3 copies),
182,Ion_trans,PF00520.30,6.6e-22,Ion transport protein,
182,Ank,PF00023.29,4.5e-14,Ankyrin repeat,
182,Ank_3,PF13606.5,7.0e-14,Ankyrin repeat,
182,Ank_4,PF13637.5,1.9e-12,Ankyrin repeats (many copies),
182,Ank_5,PF13857.5,1.9e-11,Ankyrin repeats (many copies),
183,Neur_chan_memb,PF02932.15,3.2e-10,Neurotransmitter-gated ion-channel transmembrane region,
183,Neur_chan_LBD,PF02931.22,4.5e-07,Neurotransmitter-gated ion-channel ligand binding domain,
184,Voltage_CLC,PF00654.19,3.8e-84,Voltage gated chloride channel,
185,Ion_trans,PF00520.30,2.1e-38,Ion transport protein,
185,PAS_9,PF13426.6,7.1e-18,PAS domain,
185,cNMP_binding,PF00027.28,5.3e-13,Cyclic nucleotide-binding domain,
185,Ion_trans_2,PF07885.15,1.5e-11,Ion channel,
185,PAS,PF00989.24,2.7e-07,PAS fold,
186,Neur_chan_LBD,PF02931.22,5.4e-48,Neurotransmitter-gated ion-channel ligand binding domain,
186,Neur_chan_memb,PF02932.15,2.5e-37,Neurotransmitter-gated ion-channel transmembrane region,
187,Neur_chan_LBD,PF02931.22,6.7e-50,Neurotransmitter-gated ion-channel ligand binding domain,
187,Neur_chan_memb,PF02932.15,7.9e-38,Neurotransmitter-gated ion-channel transmembrane region,
188,Clusterin,PF01093.16,1.0e-159,Clusterin,
189,Ca_hom_mod,PF14798.5,6.8e-75,Calcium homeostasis modulator,
190,Ion_trans,PF00520.30,3.0e-40,Ion transport protein,
190,BTB_2,PF02214.21,7.4e-21,BTB/POZ domain,
190,Ion_trans_2,PF07885.15,1.8e-11,Ion channel,
191,Neur_chan_memb,PF02932.15,6.0e-94,Neurotransmitter-gated ion-channel transmembrane region,
191,Neur_chan_LBD,PF02931.22,3.4e-75,Neurotransmitter-gated ion-channel ligand binding domain,
192,RYDR_ITPR,PF01365.20,2.7e-141,RIH domain,
192,RyR,PF02026.15,1.3e-125,RyR domain,
192,RR_TM4-6,PF06459.11,5.5e-95,Ryanodine Receptor TM 4-6,
192,SPRY,PF00622.27,2.0e-67,SPRY domain,
192,Ins145_P3_rec,PF08709.10,3.2e-63,Inositol 1,4,5-trisphosphate/ryanodine receptor,
192,MIR,PF02815.18,2.0e-56,MIR domain,
192,RIH_assoc,PF08454.10,1.7e-33,RyR and IP3R Homology associated,
192,Ion_trans,PF00520.30,1.6e-13,Ion transport protein,
192,EF-hand_8,PF13833.5,6.0e-07,EF-hand domain pair,
193,VGPC1_C,PF16799.4,9.9e-28,C-terminal membrane-localisation domain of ion-channel, VCN1,
193,Ion_trans,PF00520.30,3.4e-08,Ion transport protein,
194,Ion_trans,PF00520.30,3.8e-49,Ion transport protein,
194,BTB_2,PF02214.21,8.0e-29,BTB/POZ domain,
194,Ion_trans_2,PF07885.15,5.9e-14,Ion channel,
195,IRK,PF01007.19,6.2e-140,Inward rectifier potassium channel,
196,Ion_trans,PF00520.30,7.8e-28,Ion transport protein,
196,CLZ,PF16526.4,2.3e-25,C-terminal leucine zipper domain of cyclic nucleotide-gated channels,
196,cNMP_binding,PF00027.28,4.2e-18,Cyclic nucleotide-binding domain,
197,CLZ,PF16526.4,5.4e-30,C-terminal leucine zipper domain of cyclic nucleotide-gated channels,
197,Ion_trans,PF00520.30,2.6e-26,Ion transport protein,
197,cNMP_binding,PF00027.28,1.4e-17,Cyclic nucleotide-binding domain,
198,Lig_chan,PF00060.25,6.4e-39,Ligand-gated ion channel,
198,ANF_receptor,PF01094.27,2.1e-38,Receptor family ligand binding region,
198,Lig_chan-Glu_bd,PF10613.8,1.6e-32,Ligated ion channel L-glutamate- and glycine-binding site,
198,SBP_bac_3,PF00497.19,3.2e-19,Bacterial extracellular solute-binding proteins, family 3,
198,CaM_bdg_C0,PF10562.8,7.2e-14,Calmodulin-binding domain C0 of NMDA receptor NR1 subunit,
199,ATP1G1_PLM_MAT8,PF02038.15,1.7e-19,ATP1G1/PLM/MAT8 family,
200,Neur_chan_LBD,PF02931.22,1.1e-53,Neurotransmitter-gated ion-channel ligand binding domain,
200,Neur_chan_memb,PF02932.15,1.7e-38,Neurotransmitter-gated ion-channel transmembrane region,
201,Neur_chan_LBD,PF02931.22,8.8e-54,Neurotransmitter-gated ion-channel ligand binding domain,
201,Neur_chan_memb,PF02932.15,1.4e-40,Neurotransmitter-gated ion-channel transmembrane region,
202,Ion_trans_2,PF07885.15,3.1e-38,Ion channel,
202,Ion_trans,PF00520.30,6.7e-09,Ion transport protein,
203,Ion_trans,PF00520.30,8.4e-254,Ion transport protein,
203,Na_trans_assoc,PF06512.12,1.1e-61,Sodium ion transport-associated,
203,PKD_channel,PF08016.11,8.5e-07,Polycystin cation channel,
204,Ion_trans,PF00520.30,7.8e-257,Ion transport protein,
204,Na_trans_cytopl,PF11933.7,4.2e-91,Cytoplasmic domain of voltage-gated Na+ ion channel,
204,Na_trans_assoc,PF06512.12,2.4e-62,Sodium ion transport-associated,
204,PKD_channel,PF08016.11,2.2e-07,Polycystin cation channel,
205,Sulfate_transp,PF00916.19,9.4e-127,Sulfate permease family,
205,STAS,PF01740.20,2.1e-23,STAS domain,
206,VGCC_alpha2,PF08473.10,7.3e-40,Neuronal voltage-dependent calcium channel alpha 2acd,
206,VWA_N,PF08399.10,7.9e-38,VWA N-terminal,
206,VWA_3,PF13768.5,5.1e-16,von Willebrand factor type A domain,
206,dCache_1,PF02743.17,1.7e-12,Cache domain,
206,VWA,PF00092.27,2.5e-11,von Willebrand factor type A domain,
206,VWA_2,PF13519.5,1.7e-09,von Willebrand factor type A domain,
207,PKD_channel,PF08016.11,1.1e-37,Polycystin cation channel,
207,PLAT,PF01477.22,3.5e-21,PLAT/LH2 domain,
207,Ion_trans,PF00520.30,7.1e-10,Ion transport protein,
207,GPS,PF01825.20,5.3e-08,GPCR proteolysis site, GPS, motif,
207,Lectin_C,PF00059.20,1.5e-06,Lectin C-type domain,
208,PKD_channel,PF08016.11,7.9e-102,Polycystin cation channel,
208,PLAT,PF01477.22,4.6e-21,PLAT/LH2 domain,
208,Lectin_C,PF00059.20,2.2e-15,Lectin C-type domain,
208,Gal_Lectin,PF02140.17,1.7e-15,Galactose binding lectin domain,
208,Ion_trans,PF00520.30,7.2e-14,Ion transport protein,
208,REJ,PF02010.14,2.3e-10,REJ domain,
208,GPS,PF01825.20,6.9e-09,GPCR proteolysis site, GPS, motif,
209,GRIN_C,PF15235.5,1.7e-39,G protein-regulated inducer of neurite outgrowth C-terminus,
210,V-set,PF07686.16,3.4e-16,Immunoglobulin V-set domain,
211,Kv2channel,PF03521.13,9.5e-153,Kv2 voltage-gated K+ channel,
211,Ion_trans,PF00520.30,1.1e-49,Ion transport protein,
211,BTB_2,PF02214.21,3.2e-32,BTB/POZ domain,
211,Ion_trans_2,PF07885.15,7.2e-12,Ion channel,
212,SK_channel,PF03530.13,2.0e-48,Calcium-activated SK potassium channel,
212,CaMBD,PF02888.15,7.3e-36,Calmodulin binding domain,
212,Ion_trans_2,PF07885.15,3.5e-13,Ion channel,
213,Guanylate_kin,PF00625.20,3.8e-47,Guanylate kinase,
213,VGCC_beta4Aa_N,PF12052.7,2.6e-22,Voltage gated calcium channel subunit beta domain 4Aa N terminal,
215,Ank_2,PF12796.6,1.2e-97,Ankyrin repeats (3 copies),
215,Ank,PF00023.29,1.2e-60,Ankyrin repeat,
215,Ank_4,PF13637.5,1.5e-59,Ankyrin repeats (many copies),
215,Ank_3,PF13606.5,6.3e-57,Ankyrin repeat,
215,Ank_5,PF13857.5,3.0e-54,Ankyrin repeats (many copies),
215,Ion_trans,PF00520.30,1.2e-13,Ion transport protein,
216,Neur_chan_LBD,PF02931.22,7.8e-50,Neurotransmitter-gated ion-channel ligand binding domain,
216,Neur_chan_memb,PF02932.15,1.0e-38,Neurotransmitter-gated ion-channel transmembrane region,
217,ATP1G1_PLM_MAT8,PF02038.15,3.0e-23,ATP1G1/PLM/MAT8 family,
218,ATP1G1_PLM_MAT8,PF02038.15,1.2e-21,ATP1G1/PLM/MAT8 family,
219,TRIC,PF05197.12,7.7e-83,TRIC channel,
220,Neur_chan_LBD,PF02931.22,3.0e-46,Neurotransmitter-gated ion-channel ligand binding domain,
220,Neur_chan_memb,PF02932.15,2.1e-35,Neurotransmitter-gated ion-channel transmembrane region,
221,Neur_chan_LBD,PF02931.22,2.4e-50,Neurotransmitter-gated ion-channel ligand binding domain,
221,Neur_chan_memb,PF02932.15,6.7e-49,Neurotransmitter-gated ion-channel transmembrane region,
222,Orai-1,PF07856.11,6.1e-71,Mediator of CRAC channel activity,
223,ATP1G1_PLM_MAT8,PF02038.15,3.6e-28,ATP1G1/PLM/MAT8 family,
224,Ion_trans_2,PF07885.15,1.5e-32,Ion channel,
225,Claudin_2,PF13903.5,4.2e-21,PMP-22/EMP/MP20/Claudin tight junction,
225,PMP22_Claudin,PF00822.19,3.6e-20,PMP-22/EMP/MP20/Claudin family,
226,PKD_channel,PF08016.11,3.3e-10,Polycystin cation channel,
227,Anoctamin,PF04547.11,2.8e-158,Calcium-activated chloride channel,
227,Anoct_dimer,PF16178.4,4.1e-84,Dimerisation domain of Ca+-activated chloride-channel, anoctamin,
228,Neur_chan_LBD,PF02931.22,5.7e-56,Neurotransmitter-gated ion-channel ligand binding domain,
228,Neur_chan_memb,PF02932.15,2.4e-41,Neurotransmitter-gated ion-channel transmembrane region,
229,P2X_receptor,PF00864.18,5.0e-135,ATP P2X receptor,
230,VGCC_alpha2,PF08473.10,1.7e-37,Neuronal voltage-dependent calcium channel alpha 2acd,
230,VWA_N,PF08399.10,4.2e-37,VWA N-terminal,
230,dCache_1,PF02743.17,4.4e-15,Cache domain,
230,VWA_3,PF13768.5,1.3e-14,von Willebrand factor type A domain,
230,VWA,PF00092.27,1.3e-11,von Willebrand factor type A domain,
230,VWA_2,PF13519.5,2.1e-09,von Willebrand factor type A domain,
231,Ion_trans,PF00520.30,4.9e-138,Ion transport protein,
231,PKD_channel,PF08016.11,1.2e-05,Polycystin cation channel,
232,Ion_trans,PF00520.30,8.5e-247,Ion transport protein,
232,GPHH,PF16905.4,5.1e-37,Voltage-dependent L-type calcium channel, IQ-associated,
232,Ca_chan_IQ,PF08763.10,6.4e-31,Voltage gated calcium channel IQ domain,
232,PKD_channel,PF08016.11,6.5e-06,Polycystin cation channel,
233,Bestrophin,PF01062.20,8.6e-110,Bestrophin, RFP-TM, chloride channel,
234,Neur_chan_LBD,PF02931.22,8.0e-48,Neurotransmitter-gated ion-channel ligand binding domain,
234,Neur_chan_memb,PF02932.15,1.2e-23,Neurotransmitter-gated ion-channel transmembrane region,
235,P2X_receptor,PF00864.18,1.1e-145,ATP P2X receptor,
236,Ion_trans,PF00520.30,7.2e-33,Ion transport protein,
236,TRP_2,PF08344.10,3.4e-28,Transient receptor ion channel II,
236,Ank_2,PF12796.6,9.8e-10,Ankyrin repeats (3 copies),
236,Ank_4,PF13637.5,9.7e-10,Ankyrin repeats (many copies),
236,Ank_3,PF13606.5,2.2e-06,Ankyrin repeat,
236,Ank,PF00023.29,7.8e-05,Ankyrin repeat,
238,PKD_channel,PF08016.11,6.1e-12,Polycystin cation channel,
239,SK_channel,PF03530.13,2.0e-48,Calcium-activated SK potassium channel,
239,CaMBD,PF02888.15,7.6e-40,Calmodulin binding domain,
239,Ion_trans_2,PF07885.15,6.9e-13,Ion channel,
240,Ion_trans,PF00520.30,2.3e-35,Ion transport protein,
240,TRP_2,PF08344.10,1.1e-26,Transient receptor ion channel II,
240,PKD_channel,PF08016.11,3.9e-14,Polycystin cation channel,
240,Ank_2,PF12796.6,2.2e-11,Ankyrin repeats (3 copies),
240,Ank_4,PF13637.5,1.3e-05,Ankyrin repeats (many copies),
241,P2X_receptor,PF00864.18,1.6e-174,ATP P2X receptor,
243,P2X_receptor,PF00864.18,1.8e-158,ATP P2X receptor,
244,Ion_trans,PF00520.30,2.8e-250,Ion transport protein,
244,CAC1F_C,PF16885.4,4.7e-158,Voltage-gated calcium channel subunit alpha, C-term,
244,GPHH,PF16905.4,3.1e-35,Voltage-dependent L-type calcium channel, IQ-associated,
244,Ca_chan_IQ,PF08763.10,8.8e-30,Voltage gated calcium channel IQ domain,
244,PKD_channel,PF08016.11,4.8e-09,Polycystin cation channel,
245,Ion_trans_2,PF07885.15,6.4e-35,Ion channel,
246,PMP22_Claudin,PF00822.19,1.4e-50,PMP-22/EMP/MP20/Claudin family,
246,Claudin_2,PF13903.5,2.6e-20,PMP-22/EMP/MP20/Claudin tight junction,
247,Lig_chan,PF00060.25,1.2e-28,Ligand-gated ion channel,
247,Lig_chan-Glu_bd,PF10613.8,3.1e-26,Ligated ion channel L-glutamate- and glycine-binding site,
247,SBP_bac_3,PF00497.19,3.1e-19,Bacterial extracellular solute-binding proteins, family 3,
248,Neur_chan_LBD,PF02931.22,9.9e-68,Neurotransmitter-gated ion-channel ligand binding domain,
248,Neur_chan_memb,PF02932.15,2.5e-50,Neurotransmitter-gated ion-channel transmembrane region,
249,Ion_trans,PF00520.30,3.1e-256,Ion transport protein,
249,PKD_channel,PF08016.11,2.5e-16,Polycystin cation channel,
250,Neur_chan_LBD,PF02931.22,9.3e-51,Neurotransmitter-gated ion-channel ligand binding domain,
250,Neur_chan_memb,PF02932.15,3.2e-33,Neurotransmitter-gated ion-channel transmembrane region,
251,ASC,PF00858.23,9.2e-107,Amiloride-sensitive sodium channel,
252,Ion_trans,PF00520.30,1.9e-12,Ion transport protein,
253,Neur_chan_LBD,PF02931.22,3.7e-49,Neurotransmitter-gated ion-channel ligand binding domain,
253,Neur_chan_memb,PF02932.15,4.0e-39,Neurotransmitter-gated ion-channel transmembrane region,
254,Ion_trans_2,PF07885.15,2.2e-37,Ion channel,
254,Ion_trans,PF00520.30,7.1e-07,Ion transport protein,
255,CaKB,PF03185.14,4.0e-63,Calcium-activated potassium channel, beta subunit,
256,Lig_chan,PF00060.25,8.0e-29,Ligand-gated ion channel,
256,Lig_chan-Glu_bd,PF10613.8,4.3e-27,Ligated ion channel L-glutamate- and glycine-binding site,
256,SBP_bac_3,PF00497.19,4.5e-21,Bacterial extracellular solute-binding proteins, family 3,
256,ANF_receptor,PF01094.27,3.9e-08,Receptor family ligand binding region,
257,Neur_chan_LBD,PF02931.22,2.9e-21,Neurotransmitter-gated ion-channel ligand binding domain,
258,CLCA,PF08434.10,1.0e-138,Calcium-activated chloride channel N terminal,
258,VWA_2,PF13519.5,1.7e-11,von Willebrand factor type A domain,
258,VWA,PF00092.27,3.3e-09,von Willebrand factor type A domain,
259,CaKB,PF03185.14,3.1e-87,Calcium-activated potassium channel, beta subunit,
260,BK_channel_a,PF03493.17,2.5e-31,Calcium-activated BK potassium channel alpha subunit,
260,Ion_trans_2,PF07885.15,7.7e-14,Ion channel,
261,Ion_trans_2,PF07885.15,4.4e-37,Ion channel,
261,Ion_trans,PF00520.30,2.5e-08,Ion transport protein,
262,Neur_chan_LBD,PF02931.22,2.1e-64,Neurotransmitter-gated ion-channel ligand binding domain,
262,Neur_chan_memb,PF02932.15,8.2e-57,Neurotransmitter-gated ion-channel transmembrane region,
263,Ion_trans,PF00520.30,1.4e-256,Ion transport protein,
263,PKD_channel,PF08016.11,1.1e-15,Polycystin cation channel,
264,Ion_trans,PF00520.30,8.2e-38,Ion transport protein,
264,PAS_9,PF13426.6,1.1e-17,PAS domain,
264,cNMP_binding,PF00027.28,2.4e-14,Cyclic nucleotide-binding domain,
264,Ion_trans_2,PF07885.15,1.0e-12,Ion channel,
264,PAS,PF00989.24,7.5e-07,PAS fold,
265,Neur_chan_LBD,PF02931.22,1.3e-48,Neurotransmitter-gated ion-channel ligand binding domain,
265,Neur_chan_memb,PF02932.15,1.6e-19,Neurotransmitter-gated ion-channel transmembrane region,
266,Ion_trans_2,PF07885.15,7.8e-30,Ion channel,
267,Neur_chan_LBD,PF02931.22,7.5e-64,Neurotransmitter-gated ion-channel ligand binding domain,
267,Neur_chan_memb,PF02932.15,7.4e-41,Neurotransmitter-gated ion-channel transmembrane region,
268,RYDR_ITPR,PF01365.20,9.7e-137,RIH domain,
268,RyR,PF02026.15,9.3e-123,RyR domain,
268,RR_TM4-6,PF06459.11,5.1e-97,Ryanodine Receptor TM 4-6,
268,SPRY,PF00622.27,2.5e-65,SPRY domain,
268,MIR,PF02815.18,8.6e-60,MIR domain,
268,Ins145_P3_rec,PF08709.10,3.2e-59,Inositol 1,4,5-trisphosphate/ryanodine receptor,
268,RIH_assoc,PF08454.10,4.6e-30,RyR and IP3R Homology associated,
268,Ion_trans,PF00520.30,8.5e-14,Ion transport protein,
269,KCNQ_channel,PF03520.13,2.2e-88,KCNQ voltage-gated potassium channel,
269,Ion_trans,PF00520.30,4.6e-27,Ion transport protein,
269,Ion_trans_2,PF07885.15,2.4e-14,Ion channel,
270,PKD_channel,PF08016.11,3.8e-10,Polycystin cation channel,
271,cNMP_binding,PF00027.28,2.8e-17,Cyclic nucleotide-binding domain,
272,Ion_trans,PF00520.30,2.2e-43,Ion transport protein,
272,BTB_2,PF02214.21,2.2e-26,BTB/POZ domain,
272,Ion_trans_2,PF07885.15,5.3e-10,Ion channel,
272,Potassium_chann,PF11404.7,2.9e-07,Potassium voltage-gated channel,
273,P2X_receptor,PF00864.18,1.7e-149,ATP P2X receptor,
274,Neur_chan_LBD,PF02931.22,4.5e-74,Neurotransmitter-gated ion-channel ligand binding domain,
274,Neur_chan_memb,PF02932.15,4.0e-66,Neurotransmitter-gated ion-channel transmembrane region,
275,Ion_trans,PF00520.30,5.7e-23,Ion transport protein,
275,Ion_trans_N,PF08412.9,6.3e-20,Ion transport protein N-terminal,
275,cNMP_binding,PF00027.28,6.2e-16,Cyclic nucleotide-binding domain,
276,TMC,PF07810.12,4.3e-37,TMC domain,
277,TMC,PF07810.12,1.1e-36,TMC domain,
278,Neur_chan_LBD,PF02931.22,1.0e-69,Neurotransmitter-gated ion-channel ligand binding domain,
278,Neur_chan_memb,PF02932.15,1.6e-58,Neurotransmitter-gated ion-channel transmembrane region,
279,RYDR_ITPR,PF01365.20,2.3e-132,RIH domain,
279,RyR,PF02026.15,2.6e-121,RyR domain,
279,RR_TM4-6,PF06459.11,8.9e-77,Ryanodine Receptor TM 4-6,
279,SPRY,PF00622.27,5.5e-68,SPRY domain,
279,Ins145_P3_rec,PF08709.10,7.5e-62,Inositol 1,4,5-trisphosphate/ryanodine receptor,
279,MIR,PF02815.18,6.5e-54,MIR domain,
279,RIH_assoc,PF08454.10,1.1e-32,RyR and IP3R Homology associated,
279,Ion_trans,PF00520.30,1.0e-13,Ion transport protein,
279,EF-hand_8,PF13833.5,1.1e-07,EF-hand domain pair,
280,Ion_trans_2,PF07885.15,9.8e-38,Ion channel,
281,Ion_trans,PF00520.30,3.6e-38,Ion transport protein,
281,BTB_2,PF02214.21,1.3e-25,BTB/POZ domain,
281,Ion_trans_2,PF07885.15,2.9e-12,Ion channel,
282,Ion_trans,PF00520.30,7.1e-38,Ion transport protein,
282,BTB_2,PF02214.21,1.8e-19,BTB/POZ domain,
282,Ion_trans_2,PF07885.15,2.2e-13,Ion channel,
283,ANF_receptor,PF01094.27,8.7e-57,Receptor family ligand binding region,
283,Lig_chan,PF00060.25,2.0e-48,Ligand-gated ion channel,
283,Lig_chan-Glu_bd,PF10613.8,2.3e-43,Ligated ion channel L-glutamate- and glycine-binding site,
283,SBP_bac_3,PF00497.19,3.4e-18,Bacterial extracellular solute-binding proteins, family 3,
284,PKD_channel,PF08016.11,2.8e-166,Polycystin cation channel,
284,Ion_trans,PF00520.30,5.0e-28,Ion transport protein,
285,Piezo_RRas_bdg,PF12166.7,1.7e-161,Piezo non-specific cation channel, R-Ras-binding domain,
285,PIEZO,PF15917.4,3.7e-102,Piezo,
286,TMC,PF07810.12,1.8e-40,TMC domain,
287,GST_C_2,PF13410.5,1.4e-10,Glutathione S-transferase, C-terminal domain,
287,GST_N_2,PF13409.5,1.0e-07,Glutathione S-transferase, N-terminal domain,
287,GST_N_3,PF13417.5,3.8e-07,Glutathione S-transferase, N-terminal domain,
287,GST_C,PF00043.24,3.9e-05,Glutathione S-transferase, C-terminal domain,
288,ANF_receptor,PF01094.27,1.5e-61,Receptor family ligand binding region,
288,Lig_chan,PF00060.25,2.6e-48,Ligand-gated ion channel,
288,Lig_chan-Glu_bd,PF10613.8,2.0e-44,Ligated ion channel L-glutamate- and glycine-binding site,
288,SBP_bac_3,PF00497.19,6.2e-20,Bacterial extracellular solute-binding proteins, family 3,
289,BK_channel_a,PF03493.17,9.8e-30,Calcium-activated BK potassium channel alpha subunit,
289,Ion_trans_2,PF07885.15,2.7e-12,Ion channel,
290,ASC,PF00858.23,3.3e-93,Amiloride-sensitive sodium channel,
291,IRK,PF01007.19,3.0e-139,Inward rectifier potassium channel,
292,cNMP_binding,PF00027.28,2.6e-17,Cyclic nucleotide-binding domain,
293,Ion_trans,PF00520.30,8.0e-254,Ion transport protein,
293,Na_trans_assoc,PF06512.12,2.5e-58,Sodium ion transport-associated,
293,Na_trans_cytopl,PF11933.7,9.3e-53,Cytoplasmic domain of voltage-gated Na+ ion channel,
293,PKD_channel,PF08016.11,2.3e-12,Polycystin cation channel,
294,Ion_trans,PF00520.30,6.5e-34,Ion transport protein,
294,PAS_9,PF13426.6,1.7e-19,PAS domain,
294,Ion_trans_2,PF07885.15,1.2e-10,Ion channel,
294,cNMP_binding,PF00027.28,3.4e-09,Cyclic nucleotide-binding domain,
294,PAS_3,PF08447.11,7.9e-08,PAS fold,
294,PAS_4,PF08448.9,8.6e-06,PAS fold,
294,PAS,PF00989.24,8.3e-06,PAS fold,
295,KCNQ_channel,PF03520.13,2.1e-94,KCNQ voltage-gated potassium channel,
295,Ion_trans,PF00520.30,4.6e-26,Ion transport protein,
295,Ion_trans_2,PF07885.15,3.7e-14,Ion channel,
296,Ion_trans,PF00520.30,1.3e-245,Ion transport protein,
296,GPHH,PF16905.4,8.6e-36,Voltage-dependent L-type calcium channel, IQ-associated,
296,Ca_chan_IQ,PF08763.10,2.3e-28,Voltage gated calcium channel IQ domain,
296,PKD_channel,PF08016.11,1.2e-09,Polycystin cation channel,
297,NMDAR2_C,PF10565.8,8.0e-239,N-methyl D-aspartate receptor 2B3 C-terminus,
297,Lig_chan,PF00060.25,6.0e-34,Ligand-gated ion channel,
297,Lig_chan-Glu_bd,PF10613.8,3.9e-30,Ligated ion channel L-glutamate- and glycine-binding site,
297,SBP_bac_3,PF00497.19,4.9e-24,Bacterial extracellular solute-binding proteins, family 3,
297,ANF_receptor,PF01094.27,1.7e-13,Receptor family ligand binding region,
298,Ion_trans,PF00520.30,1.9e-258,Ion transport protein,
298,Na_trans_cytopl,PF11933.7,2.3e-78,Cytoplasmic domain of voltage-gated Na+ ion channel,
298,Na_trans_assoc,PF06512.12,3.0e-58,Sodium ion transport-associated,
298,PKD_channel,PF08016.11,2.2e-06,Polycystin cation channel,
299,Ins145_P3_rec,PF08709.10,7.4e-95,Inositol 1,4,5-trisphosphate/ryanodine receptor,
299,RYDR_ITPR,PF01365.20,3.6e-72,RIH domain,
299,MIR,PF02815.18,8.1e-72,MIR domain,
299,RIH_assoc,PF08454.10,2.5e-31,RyR and IP3R Homology associated,
299,Ion_trans,PF00520.30,1.9e-19,Ion transport protein,
300,IRK,PF01007.19,1.1e-136,Inward rectifier potassium channel,
301,ASC,PF00858.23,8.1e-109,Amiloride-sensitive sodium channel,
302,Aldo_ket_red,PF00248.20,6.4e-74,Aldo/keto reductase family,
303,Neur_chan_LBD,PF02931.22,1.1e-46,Neurotransmitter-gated ion-channel ligand binding domain,
303,Neur_chan_memb,PF02932.15,6.3e-29,Neurotransmitter-gated ion-channel transmembrane region,
304,Guanylate_kin,PF00625.20,8.2e-50,Guanylate kinase,
304,VGCC_beta4Aa_N,PF12052.7,1.7e-22,Voltage gated calcium channel subunit beta domain 4Aa N terminal,
305,PKD_channel,PF08016.11,1.7e-153,Polycystin cation channel,
305,REJ,PF02010.14,5.9e-107,REJ domain,
305,PLAT,PF01477.22,9.7e-22,PLAT/LH2 domain,
305,Ion_trans,PF00520.30,2.4e-07,Ion transport protein,
306,Ion_trans,PF00520.30,2.4e-43,Ion transport protein,
306,BTB_2,PF02214.21,1.6e-32,BTB/POZ domain,
306,Ion_trans_2,PF07885.15,1.4e-12,Ion channel,
307,Neur_chan_LBD,PF02931.22,5.5e-72,Neurotransmitter-gated ion-channel ligand binding domain,
307,Neur_chan_memb,PF02932.15,1.3e-61,Neurotransmitter-gated ion-channel transmembrane region,
308,Neur_chan_memb,PF02932.15,8.0e-107,Neurotransmitter-gated ion-channel transmembrane region,
308,Neur_chan_LBD,PF02931.22,1.5e-76,Neurotransmitter-gated ion-channel ligand binding domain,
309,Ion_trans,PF00520.30,3.4e-37,Ion transport protein,
309,PAS_9,PF13426.6,1.2e-18,PAS domain,
309,cNMP_binding,PF00027.28,1.5e-12,Cyclic nucleotide-binding domain,
309,Ion_trans_2,PF07885.15,1.1e-11,Ion channel,
309,PAS_3,PF08447.11,4.6e-06,PAS fold,
309,PAS,PF00989.24,2.4e-05,PAS fold,
310,EF-hand_7,PF13499.5,3.3e-24,EF-hand domain pair,
310,EF-hand_1,PF00036.31,6.9e-22,EF hand,
310,EF-hand_6,PF13405.5,1.1e-19,EF-hand domain,
310,EF-hand_5,PF13202.5,6.6e-18,EF hand,
310,EF-hand_8,PF13833.5,2.0e-15,EF-hand domain pair,
310,SPARC_Ca_bdg,PF10591.8,3.0e-06,Secreted protein acidic and rich in cysteine Ca binding region,
311,Ion_trans_2,PF07885.15,5.9e-31,Ion channel,
312,Ion_trans_2,PF07885.15,2.2e-30,Ion channel,
313,LRR_8,PF13855.5,9.5e-21,Leucine rich repeat,
313,LRR_4,PF12799.6,8.2e-18,Leucine Rich repeats (2 copies),
313,LRR_5,PF13306.5,1.1e-07,Leucine rich repeats (6 copies),
314,IRK,PF01007.19,6.4e-158,Inward rectifier potassium channel,
314,IRK_N,PF08466.9,1.4e-24,Inward rectifier potassium channel N-terminal,
315,EF-hand_7,PF13499.5,1.6e-24,EF-hand domain pair,
315,EF-hand_1,PF00036.31,2.2e-21,EF hand,
315,EF-hand_6,PF13405.5,8.9e-19,EF-hand domain,
315,EF-hand_5,PF13202.5,2.9e-17,EF hand,
315,EF-hand_8,PF13833.5,2.1e-14,EF-hand domain pair,
315,SPARC_Ca_bdg,PF10591.8,3.9e-08,Secreted protein acidic and rich in cysteine Ca binding region,
316,IRK,PF01007.19,3.7e-89,Inward rectifier potassium channel,
317,TMC,PF07810.12,1.9e-39,TMC domain,
318,V-set,PF07686.16,9.6e-23,Immunoglobulin V-set domain,
318,ig,PF00047.24,4.6e-05,Immunoglobulin domain,
319,Ca_hom_mod,PF14798.5,8.8e-88,Calcium homeostasis modulator,
320,Ion_trans,PF00520.30,3.8e-44,Ion transport protein,
320,DUF3399,PF11879.7,5.2e-39,Domain of unknown function (DUF3399),
320,BTB_2,PF02214.21,3.0e-30,BTB/POZ domain,
320,Ion_trans_2,PF07885.15,5.2e-13,Ion channel,
320,Shal-type,PF11601.7,4.0e-13,Shal-type voltage-gated potassium channels, N-terminal,
320,BTB_3,PF16017.4,2.3e-07,BTB/POZ domain,
320,PKD_channel,PF08016.11,0.00016,Polycystin cation channel,
321,Neur_chan_memb,PF02932.15,1.7e-94,Neurotransmitter-gated ion-channel transmembrane region,
321,Neur_chan_LBD,PF02931.22,2.0e-80,Neurotransmitter-gated ion-channel ligand binding domain,
322,Neur_chan_memb,PF02932.15,5.1e-86,Neurotransmitter-gated ion-channel transmembrane region,
322,Neur_chan_LBD,PF02931.22,3.6e-77,Neurotransmitter-gated ion-channel ligand binding domain,
323,Ins145_P3_rec,PF08709.10,4.2e-97,Inositol 1,4,5-trisphosphate/ryanodine receptor,
323,RYDR_ITPR,PF01365.20,2.7e-73,RIH domain,
323,MIR,PF02815.18,1.0e-68,MIR domain,
323,RIH_assoc,PF08454.10,2.0e-31,RyR and IP3R Homology associated,
323,Ion_trans,PF00520.30,1.2e-15,Ion transport protein,
324,Ins145_P3_rec,PF08709.10,2.4e-91,Inositol 1,4,5-trisphosphate/ryanodine receptor,
324,RYDR_ITPR,PF01365.20,8.1e-75,RIH domain,
324,MIR,PF02815.18,7.2e-71,MIR domain,
324,RIH_assoc,PF08454.10,4.5e-31,RyR and IP3R Homology associated,
324,Ion_trans,PF00520.30,2.7e-17,Ion transport protein,
325,Ca_hom_mod,PF14798.5,1.6e-96,Calcium homeostasis modulator,
326,Tweety,PF04906.12,1.3e-176,Tweety,
327,Ion_trans,PF00520.30,4.4e-42,Ion transport protein,
327,BTB_2,PF02214.21,1.1e-26,BTB/POZ domain,
327,Ion_trans_2,PF07885.15,7.5e-11,Ion channel,
328,Ion_trans,PF00520.30,4.3e-187,Ion transport protein,
328,Na_trans_assoc,PF06512.12,3.3e-20,Sodium ion transport-associated,
329,Neur_chan_LBD,PF02931.22,1.0e-51,Neurotransmitter-gated ion-channel ligand binding domain,
329,Neur_chan_memb,PF02932.15,7.9e-41,Neurotransmitter-gated ion-channel transmembrane region,
330,Neur_chan_LBD,PF02931.22,2.4e-50,Neurotransmitter-gated ion-channel ligand binding domain,
330,Neur_chan_memb,PF02932.15,5.6e-48,Neurotransmitter-gated ion-channel transmembrane region,
331,Ion_trans,PF00520.30,2.2e-257,Ion transport protein,
331,Na_trans_cytopl,PF11933.7,5.0e-81,Cytoplasmic domain of voltage-gated Na+ ion channel,
331,Na_trans_assoc,PF06512.12,8.4e-66,Sodium ion transport-associated,
331,PKD_channel,PF08016.11,8.9e-07,Polycystin cation channel,
332,Ion_trans,PF00520.30,8.2e-44,Ion transport protein,
332,BTB_2,PF02214.21,1.6e-23,BTB/POZ domain,
332,Potassium_chann,PF11404.7,2.6e-20,Potassium voltage-gated channel,
332,Ion_trans_2,PF07885.15,7.4e-11,Ion channel,
333,Neur_chan_LBD,PF02931.22,1.2e-48,Neurotransmitter-gated ion-channel ligand binding domain,
333,Neur_chan_memb,PF02932.15,2.8e-37,Neurotransmitter-gated ion-channel transmembrane region,
334,PMP22_Claudin,PF00822.19,5.7e-23,PMP-22/EMP/MP20/Claudin family,
334,Claudin_2,PF13903.5,5.7e-22,PMP-22/EMP/MP20/Claudin tight junction,
335,Guanylate_kin,PF00625.20,3.9e-46,Guanylate kinase,
335,VGCC_beta4Aa_N,PF12052.7,6.4e-20,Voltage gated calcium channel subunit beta domain 4Aa N terminal,
336,VGCC_alpha2,PF08473.10,7.9e-214,Neuronal voltage-dependent calcium channel alpha 2acd,
336,VWA_N,PF08399.10,2.9e-40,VWA N-terminal,
336,VWA,PF00092.27,2.7e-21,von Willebrand factor type A domain,
336,VWA_3,PF13768.5,2.1e-15,von Willebrand factor type A domain,
336,dCache_1,PF02743.17,6.0e-12,Cache domain,
336,VWA_2,PF13519.5,3.5e-11,von Willebrand factor type A domain,
337,Ank_2,PF12796.6,2.0e-24,Ankyrin repeats (3 copies),
337,Ion_trans,PF00520.30,8.6e-19,Ion transport protein,
337,Ank_3,PF13606.5,1.5e-16,Ankyrin repeat,
337,Ank,PF00023.29,1.4e-14,Ankyrin repeat,
337,Ank_4,PF13637.5,2.6e-13,Ankyrin repeats (many copies),
337,Ank_5,PF13857.5,2.5e-13,Ankyrin repeats (many copies),
338,ANF_receptor,PF01094.27,6.9e-82,Receptor family ligand binding region,
338,Lig_chan,PF00060.25,4.2e-55,Ligand-gated ion channel,
338,Lig_chan-Glu_bd,PF10613.8,2.6e-46,Ligated ion channel L-glutamate- and glycine-binding site,
338,SBP_bac_3,PF00497.19,6.7e-18,Bacterial extracellular solute-binding proteins, family 3,
338,Peripla_BP_6,PF13458.5,5.6e-09,Periplasmic binding protein,
339,ANF_receptor,PF01094.27,2.0e-73,Receptor family ligand binding region,
339,Lig_chan,PF00060.25,3.2e-53,Ligand-gated ion channel,
339,Lig_chan-Glu_bd,PF10613.8,1.1e-46,Ligated ion channel L-glutamate- and glycine-binding site,
339,SBP_bac_3,PF00497.19,5.5e-19,Bacterial extracellular solute-binding proteins, family 3,
340,IRK,PF01007.19,2.2e-129,Inward rectifier potassium channel,
341,Ion_trans,PF00520.30,3.7e-21,Ion transport protein,
341,Ion_trans_N,PF08412.9,3.9e-21,Ion transport protein N-terminal,
341,cNMP_binding,PF00027.28,9.1e-18,Cyclic nucleotide-binding domain,
342,ANF_receptor,PF01094.27,2.5e-60,Receptor family ligand binding region,
342,Lig_chan,PF00060.25,4.0e-59,Ligand-gated ion channel,
342,Lig_chan-Glu_bd,PF10613.8,2.6e-45,Ligated ion channel L-glutamate- and glycine-binding site,
342,SBP_bac_3,PF00497.19,2.0e-23,Bacterial extracellular solute-binding proteins, family 3,
343,ANF_receptor,PF01094.27,6.0e-60,Receptor family ligand binding region,
343,Lig_chan,PF00060.25,3.1e-59,Ligand-gated ion channel,
343,Lig_chan-Glu_bd,PF10613.8,9.5e-46,Ligated ion channel L-glutamate- and glycine-binding site,
343,SBP_bac_3,PF00497.19,1.3e-24,Bacterial extracellular solute-binding proteins, family 3,
344,ANF_receptor,PF01094.27,1.7e-70,Receptor family ligand binding region,
344,Lig_chan,PF00060.25,1.4e-59,Ligand-gated ion channel,
344,Lig_chan-Glu_bd,PF10613.8,1.3e-44,Ligated ion channel L-glutamate- and glycine-binding site,
344,SBP_bac_3,PF00497.19,7.8e-24,Bacterial extracellular solute-binding proteins, family 3,
345,Anoctamin,PF04547.11,1.2e-156,Calcium-activated chloride channel,
345,Anoct_dimer,PF16178.4,3.4e-79,Dimerisation domain of Ca+-activated chloride-channel, anoctamin,
346,Ca_hom_mod,PF14798.5,9.3e-89,Calcium homeostasis modulator,
